Blood gas analyzers are equipment that measure pH and concentration of hydrogen ions, partial pressure of oxygen and carbon dioxide in human blood. After the blood is collected from the patient, it is injected into the analyzer. The analyzer then measures the proportion of carbon dioxide and other gases, after which the blood is automatically expelled and the sample path is cleaned for the next test.
Browse the full EME Blood Gas and Electrolyte Analyzers Market Report:http://www.mrrse.com/eme-blood-gas-electrolyte-analyzers-market
Electrolyte analyzers are used to detect metabolic disturbances and measure cardiac and renal function, by measuring electrolyte levels. Chloride, sodium, bicarbonate, and potassium are the electrolytes measured. They are used in clinics, hospitals, reference laboratories, and even point-of-care settings. Electrolyte analyzers generally use serum, urine, or plasma samples, while some might also use whole blood and cerebrospinal fluid. They are able to conduct 400 to 2400 tests per hour, depending on their efficiency.
High Incidence of Chronic Ailments and Rising Geriatric Population are among Key Market Drivers
The market for blood gas and electrolyte analyzers will gain impetus due to the following factors:
The blood gas and electrolyte analyzers market has been segmented on the basis of product, modality, end-user, and geography. According to modality, the key segments are benchtop, portable, and laboratory. By product type, electrolyte analyzers, consumables, blood gas analyzers, and combination analyzers are the major categories. The end-user segment has further been segmented into clinics, hospitals, ambulatory surgical centers, and diagnostic centers.
Browse the full Press Release of EME Blood Gas and Electrolyte Analyzers Market at :http://www.mrrse.com/eme-blood-gas-electrolyte-analyzers-industry
The key players operating in the blood gas and electrolyte analyzers market are Alere Inc. (U.S.), Radiometer Medical ApS (Denmark), Instrumentation Laboratories (Werfen) (U.S.), Medica Corporation (U.S.), F.Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (U.S.), Nova Biomedical (U.S.), Siemens Healthcare (Germany), and ERBA Diagnostics Mannheim GmbH (Germany).